BASF ups cost of ethanolamines by €150 per tonne in Europe

By Staff Reporter

- Last updated on GMT

Image: GettyImages/Dmytro Synelnychenko
Image: GettyImages/Dmytro Synelnychenko

Related tags Ethanolamine

BASF says the second price hike within twelve months will restore sustainable margins on the back of increased costs.

As well as being an important chemical in a number of other industries, Ethanolamines (EOA) compounds are used in the pharmaceutical industry as auxiliaries in the production process of a wide range of active pharmaceutical ingredients (APIs) and excipients.

And with immediate effect, BASF customers in Europe will have to pay an extra €150 ($180) for each metric ton of monoethanolamine (MEOA), diethanolamine (DEOA) and triethanolamine (TEOA).

Company spokeswoman Klaus-Peter Rieser told in-Pharmatechnologist.com the price will restore margins to a sustainable level.

“Prices were declining in 2016/2017,”​ he said, while BASF experiences “increasing feedstock cost and additional logistical cost.”

The price increase applies to current supply agreements as soon as, and to the extent permitted by, the terms and conditions of the customer contracts.

The cost of ethanolamines has continued to rise. In October last year​ BASF added an extra €100 per tonne across its ethanolamine range. In 2015​ the price increased by €55 per tonne, while in 2014​ the price increased on the back of continuous demand.

Ethanolamines are made at BASF’s Verbund sites in Ludwigshafen, Germany; Antwerp, Belgium; and Nanjing, China. Ludwigshafen experienced a deadly explosion in 2016​ which halted production at 20 facilities at the site.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars